TETRACYCLINE 250 MG — DIN 00580929
TETRACYCLINE HYDROCHLORIDE : 250 MG · AA PHARMA INC · CAPSULE · wholesale supply in Canada
Health Canada status: MARKETED
What is TETRACYCLINE?
TETRACYCLINE 250 MG contains TETRACYCLINE HYDROCHLORIDE : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 00580929, held by AA PHARMA INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 12-Jul-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Tetracycline cost around the world?
Tetracycline is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Greece publishes a producer price (ex-factory); Lebanon publishes a public price (USD, Decision 119/1); Morocco publishes a PPV (public price). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed |
|---|---|---|---|
| United States | acquisition | 2 | 14 |
| Saudi Arabia | public | 13 | 13 |
| Morocco | PPV (public price) | 4 | 6 |
| Greece | producer price (ex-factory) | 2 | 2 |
| Lebanon | public price (USD, Decision 119/1) | 1 | 2 |
| United Arab Emirates | public | 1 | 1 |
| United Kingdom | hospital | 1 | 1 |
| South Africa | single exit price | 1 | 1 |
40 pack listings across 25 brand entries and 7 price bases, refreshed 05 Sep 2026. Ranges span every Tetracycline pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Tetracycline in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Tetracycline, across 12 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 1 | 1 | TETRACYCLINE | Sourceable in Canada |
| NOVOPHARM LIMITED | 3 | 0 | NOVO-TETRA 250MG, NOVO-TETRA SUS 125MG/5ML | No marketed DIN |
| APOTEX INC | 1 | 0 | APO TETRA TABS 250MG | No marketed DIN |
| DUCHESNAY INC | 1 | 0 | TETRACYCLINE CAP 250MG | No marketed DIN |
| JAAPHARM CANADA INC. | 1 | 0 | JAA TETRA TAB 250MG | No marketed DIN |
| LEDERLE CYANAMID CANADA INC. | 1 | 0 | ACHROMYCIN V CAP 250MG | No marketed DIN |
| MEDIC LABORATORY LTÉE | 1 | 0 | MEDICYCLINE CAP 250MG | No marketed DIN |
| NU-PHARM INC | 1 | 0 | NU-TETRA CAPSULES 250MG | No marketed DIN |
| PFIZER CANADA ULC | 1 | 0 | TETRACYN CAP 250MG | No marketed DIN |
| PRO DOC LIMITEE | 1 | 0 | TETRACYCLINE CAP 250MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 250 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Tetracycline |
|---|---|
| ATC code | J01AA07 |
| AHFS class | 08:12.24 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00580929 |
|---|---|
| DIN (unpadded, as printed on some documents) | 580929 |
| Brand name | TETRACYCLINE |
| Generic / active ingredient | TETRACYCLINE HYDROCHLORIDE : 250 MG |
| Market authorization holder | AA PHARMA INC |
| Health Canada schedule | Prescription |
| ATC code | J01AA07 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01AA |
| Current status | MARKETED |
| Status date | 12-Jul-2011 |
| Original market date | 1983-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Tetracycline in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by AA PHARMA INC (Tier 3 Drug Shortages About & Resources), last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 12 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACHROMYCIN V CAP 250MG | 250 MG | CAPSULE | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00014605 |
| APO TETRA TABS 250MG | 250 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | 00603252 |
| JAA TETRA TAB 250MG | 250 MG | TABLET | JAAPHARM CANADA INC. | CANCELLED POST MARKET | 00889393 |
| MEDICYCLINE CAP 250MG | 250 MG | CAPSULE | MEDIC LABORATORY LTÉE | CANCELLED POST MARKET | 00134406 |
| NOVO-TETRA 250MG | 250 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | 00021806 |
| NOVO-TETRA 250MG | 250 MG | CAPSULE | NOVOPHARM LIMITED | CANCELLED POST MARKET | 00021059 |
| NOVO-TETRA SUS 125MG/5ML | 125 MG / 5 ML | LIQUID | NOVOPHARM LIMITED | CANCELLED POST MARKET | 00151416 |
| NU-TETRA CAPSULES 250MG | 250 MG | CAPSULE | NU-PHARM INC | CANCELLED POST MARKET | 00717606 |
| TETRACYCLINE CAP 250MG | 250 MG | CAPSULE | DUCHESNAY INC | CANCELLED POST MARKET | 00448729 |
| TETRACYCLINE CAP 250MG | 250 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | 00156744 |
2 · Same class — other molecules in ATC J01AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Doxycycline | AG-DOXYCYCLINE · ALTI-DOXYCYCLINE - TAB 100MG · ALTI-DOXYCYCLINE-CAP 100MG · APO-DOXY CAP 100MG · +34 more | 43 | 14 | Yes |
| Minocycline | AVA-MINOCYCLINE · DOM-MINOCYCLINE CAPSULES · ENCA 100MG · ENCA 50MG · +16 more | 36 | 2 | Yes |
| Tigecycline | TIGECYCLINE · TIGECYCLINE FOR INJECTION · TYGACIL | 3 | 2 | Yes |
| Tetracycline | ACHROMYCIN V CAP 250MG · APO TETRA TABS 250MG · JAA TETRA TAB 250MG · MEDICYCLINE CAP 250MG · +6 more | 12 | 1 | Yes |
| Demeclocycline | DECLOMYCIN · DECLOMYCIN - TAB 300MG · DECLOMYCIN TAB 150MG · DECLOMYCIN TAB 300MG | 4 | 0 | Not in Canada |
| Rolitetracycline | REVERIN 275MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TETRACYCLINE called?
Also recorded in Canada as: bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera] (US), tetracycline hydrochloride 0.03 MG/MG Topical Ointment [Viabecline] (US), tetracycline hydrochloride 30 MG/ML Topical Spray [Vitastem] (US), bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule (US), tetracycline hydrochloride 0.03 MG/MG Topical Ointment (US), tetracycline hydrochloride 2.2 MG/ML Topical Solution (US), tetracycline hydrochloride 250 MG Oral Capsule (US), tetracycline hydrochloride 500 MG Oral Capsule (US), tetracycline hydrochloride 30 MG/ML Topical Spray (US), tetracycline hydrochloride 30 MG/ML Topical Solution (US), tetracycline hydrochloride 0.01 MG/MG Ophthalmic Ointment (US), tetracycline hydrochloride 25 MG/ML Oral Suspension (US), tetracycline hydrochloride 250 MG Oral Tablet (US), tetracycline hydrochloride 500 MG Oral Tablet (US), tetracycline hydrochloride 0.01 MG/MG Topical Ointment (US).
The same molecule, Tetracycline, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| TETRACYCLINE LAPROPHAN | Latin | Morocco |
| DUMOCYCLINE EYE OINT | Latin | Saudi Arabia |
| HOSTACYCLINE | Latin | Morocco |
| OPTICYCLIN | Latin | United Arab Emirates |
| TEPHACYCLINE | Latin | Morocco |
| TERACIN | Latin | Saudi Arabia |
| Tetracycline Hci | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.